Evidence map›Paper›PMID 35623007›Full record

ArticleCanadian Urological Association journal = Journal de l'Association des urologues du Canada2022

Canadian Urological Association consensus guideline: Management of testicular germ cell cancer.

Robert J Hamilton, Christina Canil, Noa Shani Shrem, Kopika Kuhathaas, Maria Di Jiang, Peter Chung, Scott North, Piotr Czaykowski, Sebastien Hotte, Eric Winquist and 9 more

Erratum issued Registry-linked trialAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Canadian Urological Association journal = Journal de l'Association des urologues du Canada, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to trial NCT06932458 (A Phase II Single-arm Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal Metastases), which is not on this map. Cited by 14 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06932458 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

A Phase II Single-arm Clinical Trial of Primary Retroperitoneal Lymph Node Dissection in Patients With Testicular Seminoma With Limited Retroperitoneal Metastases

TypeinterventionalSponsorWestern University, CanadaRan2025 to 2030Enrolled30ConditionsTesticular CancerArmsRetroperitoneal Lymph Node Dissection
3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Assessing complications from retroperitoneal lymph node dissection for testicular cancer in North America.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2025
    Article
  8. Restricted access and advanced disease in post-pandemic testicular cancer.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2024
    Article
  9. Article
  10. Article
  11. Article
  12. Accuracy of germ cell tumor histology and stage within a Canadian cancer registry.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2023
    Article
  13. Testicular cancer survivorship: Long-term toxicity and management.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Review
  14. Updated testicular cancer consensus guideline is a concise, balanced, and practical guide for clinicians.Canadian Urological Association journal = Journal de l'Association des urologues du Canada · 2022
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors.

Robert J HamiltonDepartment of Surgical Oncology, Division of Urology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.
Christina CanilDepartment of Medicine, Division of Medical Oncology, The Ottawa Hospital and the University of Ottawa, Ottawa, ON, Canada.
Noa Shani ShremDepartment of Medicine, Division of Medical Oncology, The Ottawa Hospital and the University of Ottawa, Ottawa, ON, Canada.
Kopika KuhathaasPrincess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada.
Maria Di JiangDepartment of Medicine, Division of Medical Oncology, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, ON, Canada.
Peter ChungDepartment of Radiation Oncology, Radiation Medicine Program, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada.
Scott NorthDepartment of Oncology, Division of Medical Oncology, Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada.
Piotr CzaykowskiDepartment of Medical Oncology and Hematology, CancerCare Manitoba, Winnipeg, MB, Canada.
Sebastien HotteDivision of Medical Oncology, Juravinski Cancer Centre, Hamilton, ON, Canada.
Eric WinquistDivision of Medical Oncology, Western University and London Health Sciences Centre, London, ON, Canada.
Christian KollmannsbergerDepartment of Medical Oncology, British Columbia Cancer Agency, Vancouver, BC, Canada.
Armen AprikianDivision of Urology, Department of Surgery, McGill University Health Centre, Montreal, QC, Canada.
Denis SoulièresDivision of Medical Oncology/Hematology, Le Centre hospitalier de l'Université de Montréal, Montreal, QC, Canada.
Scott TyldesleyDepartment of Radiation Oncology, University of British Columbia, BC Cancer Vancouver, Vancouver, BC, Canada.
Alan I SoDepartment of Urologic Sciences, University of British Columbia, BC Cancer Vancouver, Vancouver, BC, Canada.
Nicholas PowerDivision of Urology, Department of Surgery, Western University, London, ON, Canada.
Ricardo A RendonDivision of Urology, Department of Surgery, Capital Health - Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.
Martin O'MalleyDepartment of Medical Imaging, University Health Network, University of Toronto, Toronto, ON, Canada.
Lori WoodDivision of Medical Oncology, Queen Elizabeth II Health Sciences Centre, Halifax, NS, Canada.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID35623007
PMCPMC9245964

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.